DEMOCRATIC REPUBLIC OF THE CONGO / RankWire.AI / – The Ebola outbreak in Congo has expanded more rapidly than any previous epidemic in the country. As of August 3, officials reported 3,874 confirmed cases and 1,751 deaths. This makes it the largest documented Ebola outbreak in Congo’s history and the second largest globally. The nation reached 1,000 cases within just 40 days after initiating its response, whereas a major outbreak starting in 2018 took approximately 235 days to surpass that number.
Health authorities officially announced the outbreak on May 15, after laboratories identified the Bundibugyo virus in Ituri province. Investigations later revealed that infections had actually started several months earlier near Mongbwalu. Many early patients displayed symptoms similar to malaria and other common illnesses. Initial lab tests primarily focused on the better-known Zaire Ebola species, which delayed recognizing the true threat. This lag allowed the virus to spread extensively within households, clinics, mining communities, and trading hubs before testing and isolation measures were scaled up.
The presence of the Bundibugyo strain has also restricted the effectiveness of available medical interventions. Currently approved Ebola vaccines and antibody treatments are designed to target Zaire ebolavirus, responsible for Congo’s 2018 to 2020 epidemic. There are no licensed vaccines or proven specific therapies for Bundibugyo virus disease at this time. Medical teams rely on rapid testing, patient isolation, supportive care, infection prevention, and safe burial practices. Although the World Health Organization has supported efforts to improve diagnostic capacity and conduct treatment research, these initiatives began after the virus had already spread to multiple regions.
Delayed detection hindered contact tracing efforts
The outbreak has extended beyond Mongbwalu into numerous health zones throughout eastern and northeastern Congo. While Ituri remains the outbreak’s epicenter, cases have also been reported in North Kivu, South Kivu, Haut-Uele, and Tshopo. As of July 30, response teams tracked 17,863 contacts, but follow-up remains inconsistent, especially in provinces affected by insecurity and difficult terrain. Many new cases have emerged outside known contact lists, indicating gaps in surveillance and the inability to identify every transmission chain.
Ongoing conflict has further complicated case detection and patient management. Armed clashes have damaged roads, disrupted health activities, and caused some teams to halt field operations. Additionally, large populations frequently move between mining sites, markets, towns, and displacement camps, making daily monitoring of exposed contacts more challenging. Healthcare facilities are also facing shortages of protective equipment, trained personnel, transportation, and laboratory access. By July 30, Congo reported 151 infections and 44 deaths among health workers, adding strain to an already overwhelmed response system.
Insecurity and lack of vaccines accelerate virus transmission
Transmission occurs mainly through direct contact with the blood or body fluids of infected individuals. The risk is heightened in homes, clinics, and burial sites lacking adequate infection control measures. Over 60% of recent fatalities happened outside designated treatment centers, complicating safe burial practices and contact tracing efforts. To combat this, Congo’s World Health Organization and the Africa CDC have expanded laboratory testing, treatment facilities, border screening, and public awareness campaigns. Nonetheless, these efforts have struggled to keep pace with the rapid and widespread nature of new infections.
Meanwhile, Uganda successfully halted its linked outbreak on July 28 after 42 days without new transmissions, and France reported no secondary spread from its single treated case. Yet Congo remains the primary site of sustained transmission, with a death rate close to 45% as of early August. The epidemic’s accelerated spread is partly due to late detection, the absence of strain-specific vaccines and treatments, missed contacts, ongoing conflict, staffing shortages, and population movements. These combined factors distinguish the current Bundibugyo outbreak from previous Ebola incidents in Congo.